Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of two different doses of mannitol on creatine phosphokinase in brain-dead patients
IRCT20200825048515N67Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jun 2023
- Modality
- Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2 trial of Bronchitol in brain death, sponsored by Isfahan University of Medical Sciences. Primary endpoint: Change in creatine phosphokinase (CPK) levels. Started Jun 2023; status: completed.
02
Drugs
Bronchitol
03
Conditions
brain death
Beyond the preview
Go deeper on IRCT20200825048515N67.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200825048515N67.